Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 242 of the 244 references it cites were found in a registry or an index.
Abstract
Mitochondria play a central role in a plethora of processes related to the maintenance of cellular homeostasis and genomic integrity. They contribute to preserving the optimal functioning of cells and protecting them from potential DNA damage which could result in mutations and disease. However, perturbations of the system due to senescence or environmental factors induce alterations of the physiological balance and lead to the impairment of mitochondrial functions. After the description of the crucial roles of mitochondria for cell survival and activity, the core of this review focuses on the “mitochondrial switch” which occurs at the onset of neuronal degeneration. We dissect the pathways related to mitochondrial dysfunctions which are shared among the most frequent or disabling neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s, Amyotrophic Lateral Sclerosis, and Spinal Muscular Atrophy. Can mitochondrial dysfunctions (affecting their morphology and activities) represent the early event eliciting the shift towards pathological neurobiological processes? Can mitochondria represent a common target against neurodegeneration? We also review here the drugs that target mitochondria in neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial dysfunction has been reported in a number of neurodegenerative diseases [3–6] and correlates with dendritic pathology and synapse disassembly [7–10].”
From AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kandimalla, R., Manczak, M., Yin, X., Wang, R., & Reddy, P. H. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx381 · Cited by 260 · cited 1×
“Neurodegenerative diseases consist of a group of heterogeneous disorders, but, nevertheless, they are all characterized by the progressive loss of specific neuronal populations and circuits in the central nervous system (CNS) triggered by mitochondria dysfunctions [23,24].”
BackgroundRetractedFree Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“Additionally, also in PD, mitochondrial dysfunctions are not limited to CNS, but also involve peripheral tissues as it has been described in skeletal muscles and platelets [62,75].”
BackgroundThe amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“AD is the most common and devastating neurodegenerative disease expected to affect more than 81 million people worldwide by 2040 [41,42].”
BackgroundA role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · cited 1×
“Interestingly, NLRP3 localizes in the cytosol and once activated it translocates into mitochondria and mitochondria-associated membranes (MAMs) [37].”
BackgroundGlobal prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 1×
“AD is the most common and devastating neurodegenerative disease expected to affect more than 81 million people worldwide by 2040 [41,42].”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · cited 1×
“The first evidence of mitochondrial dysfunction in PD came in 1983, when Langston described chronic parkinsonism effects in young humans after the use of 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP), which is a prodrug to the neurotoxin 1-methyl-4-phenylpyridinium (MPP+); the latter interferes with the activity…”
BackgroundOxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674 · cited 1×
“Indeed, the processes of fusion and fission are fundamental, respectively, to repair a damaged mitochondrion or to increment their number, as in case of an increased demand of energy or to facilitate their removal when damaged in order to protect cellular integrity [12].”
Background
Cited by
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654
Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems
Kaplan, P., Tatarkova, Z., Sivonova, M. K., Racay, P., & Lehotsky, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207698 · Cited by 196
“of the above-mentioned neurodegenerative and cardiovascular diseases [22].”
BackgroundDeregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 163
Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle
Zhang, S., Gai, Z., Gui, T., Chen, J., Chen, Q., & Li, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6139308 · Cited by 156
“PCA is also regarded as the perfect peroxyl radical scavenger in the polar environment of aqueous solutions and a relatively good anti-radical protector in nonpolar environment of lipid solutions [92].”
BackgroundFields, M., Marcuzzi, A., Gonelli, A., Celeghini, C., Maximova, N., & Rimondi, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043739 · Cited by 156
“[4] determined that mitochondrial dysfunctions represent a crucial point of convergence in the pathogenesis of such neurodegenerative pathologies.”
BackgroundStructure, mechanism, and regulation of mitochondrial DNA transcription initiation
Basu, U., Bostwick, A. M., Das, K., Dittenhafer‐Reed, K. E., & Patel, S. S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011202 · Cited by 136
“Mitochondrial genetics, metabolism, and inflammation significantly impact age-associated pathologies (221) and neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases (222, 223).”
BackgroundYan, L., Guo, M.-S., Zhang, Y., Yu, L., Wu, J.-M., Tang, Y., Ai, W., Zhu, F.-D., Law, B. Y.-K., Chen, Q., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5288698 · Cited by 97
Disentangling Mitochondria in Alzheimer’s Disease
Johri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111520 · Cited by 108
“Food and Drug Administration (USFDA) include the cholinesterase inhibitors donepezil, galantamine, and rivastigmine, which have shown low central nervous system selectivity, and an Nmethyl-D-aspartate (NMDA) receptor antagonist, memantine, which has shown limited beneficial effects in clinical trials [3,4].”
BackgroundNeuroprotective Effects of Agri-Food By-Products Rich in Phenolic Compounds
Rojas-García, A., Fernández‐Ochoa, Á., Cádiz‐Gurrea, M. D. L. L., Arraéz-Román, D., & Segura‐Carretero, A. (2023) · Nutrients · doi:10.3390/nu15020449 · Cited by 98
“(2022) in saffron stigma carotenoid-rich extract [53,130].”
BackgroundInfluentialNatural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases
Dhahri, M., Alghrably, M., Mohammed, H. A., Badshah, S. L., Noreen, N., Mouffouk, F., Rayyan, S., Qureshi, K. A., Mahmood, D., Lachowicz, J. I., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010001 · Cited by 88
“Mitochondrial dysfunctions has been widly documented in AD-relation [83,84].”
BackgroundRole of mitochondria in physiological activities, diseases, and therapy
Wang, L., Zhou, X., & Lu, T. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00284-5 · Cited by 102
“Many lines of evidence strongly suggest the involvement of mitochondria in neurodegenerative dis - eases [116, 117].”
Belforte, N., Agostinone, J., Alarcon-Martinez, L., Villafranca-Baughman, D., Dotigny, F., Cueva Vargas, J. L., & Di Polo, A. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00466-z · Cited by 67
Liang, J., Wang, C., Zhang, H., Huang, J., Xie, J., & Chen, N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.755665 · Cited by 77
Coenzyme Q10 effects in neurological diseases
Rauchová, H. (2021) · Physiological Research · doi:10.33549/physiolres.934712 · Cited by 78
Role of eIF5A in Mitochondrial Function
Barba‐Aliaga, M., & Alepuz, P. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031284 · Cited by 68
Salama, A., Elgohary, R., Amin, M. M., & Elwahab, S. A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175217 · Cited by 63
Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 63
Factors Regulating the Activity of LINE1 Retrotransposons
Protasova, M., Андреева, Т. В., & Rogaev, E. I. (2021) · Genes · doi:10.3390/genes12101562 · Cited by 69
Role of Mitochondria in Neurodegenerative Diseases: From an Epigenetic Perspective
Xu, S., Zhang, X., Liu, C., Liu, Q., Chai, H., Luo, Y., & Li, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.688789 · Cited by 59
Cachexia, a Systemic Disease beyond Muscle Atrophy
Wyart, E., Bindels, L. B., Mina, E., Menga, A., Stanga, S., & Porporato, P. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228592 · Cited by 52
“Indeed, in neurodegeneration the loss of specific neuronal populations and circuits is triggered by mitochondria dysfunctions [7,8]; furthermore, the progressive motor decline is related to the fact that mitochondria-enriched muscles are also impacted by their dysfunctions.”
BackgroundSelf-citationMolecular Machinery and Pathophysiology of Mitochondrial Dynamics
Chiu, Y., Lin, S., Kuo, C.-H., & Li, C.-J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.743892 · Cited by 54
Yang, J., Fang, L., Lu, H., Liu, C., Wang, J., Wu, D., & Min, W. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00005 · Cited by 47
Pogačnik, L., Ota, A., & Ulrih, N. P. (2020) · Cells · doi:10.3390/cells9030576 · Cited by 47
Lee, S., Suh, Y. J., Yang, S., Hong, D. G., Ishigami, A., Kim, H., Hur, J., Chang, S., & Lee, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042098 · Cited by 47
“Mitochondria are important organelles and are responsible for cellular respiration, bioenergetics, and maintaining homeostasis, and mitochondrial dysfunction is a characteristic of PD [26,32].”
BackgroundStanga, S., Boido, M., & Kienlen‐Campard, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010136 · Cited by 42
“These early phenomena are largely described both in animal models and in patients (for a recent review see [60]).”
BackgroundSelf-citationMenduti, G., Rasà, D. M., Stanga, S., & Boido, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.592234 · Cited by 41
Self-citationNazam, N., Jabir, N. R., Ahmad, I., Alharthy, S. A., Khan, M. S., Ayub, R., & Tabrez, S. S. M. (2023) · Pharmaceuticals · doi:10.3390/ph16020274 · Cited by 35
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Bhat, A. A., Moglad, E. H. O., Afzal, M., Thapa, R., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., Ali, H., Pant, K., Singh, T. G., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70053 · Cited by 33
Mitochondrial DNA and Neurodegeneration: Any Role for Dietary Antioxidants?
Bordoni, L., & Gabbianelli, R. (2020) · Antioxidants · doi:10.3390/antiox9080764 · Cited by 35
“In the light of this evidence, mtDNA depletion and malfunction have been implicated in cancer [62,63], metabolic and cardiovascular diseases [43,64–67], aging [68], and many human multifactorial disorders, including neurodegeneration [69,70].”
BackgroundMitochondrial Dysfunction in Endothelial Cells: A Key Driver of Organ Disorders and Aging
Grossini, E., Venkatesan, S., & Pour, M. M. O. (2025) · Antioxidants · doi:10.3390/antiox14040372 · Cited by 38
“…dehydrogenase, a key enzyme in glycolysis which in physiologic conditions would support mitochondrial activity via autophagy, in pathological conditions, such as those that can be found in HD, would lose this function as a consequence of its interaction with the mutant huntingtin gene [78–80].”
Atlante, A., & Valenti, D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45050283 · Cited by 40
Mushroom Polysaccharides as Potential Candidates for Alleviating Neurodegenerative Diseases
Jiang, X., Li, S., Feng, X., Li, L., Hao, J., Wang, D., & Wang, Q. (2022) · Nutrients · doi:10.3390/nu14224833 · Cited by 31
Goyal, S., Tiwari, S., Seth, B., Tandon, A., Shankar, J., Sinha, M., Singh, S. J., Priya, S., & Chaturvedi, R. K. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.04.001 · Cited by 28
Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease
Pengo, M., & Squitieri, F. (2024) · Genes · doi:10.3390/genes15060807 · Cited by 32
“Robust evidence demonstrates that mitochondrial dysfunction plays a central role in normal aging and neurodegenerative diseases [112,113].”
BackgroundCalabrese, C., Panuzzo, C., Stanga, S., Andreani, G., Ravera, S., Maglione, A., Pironi, L., Petiti, J., Ali, M. S., Scaravaglio, P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207674 · Cited by 28
“Protein concentration was determined by Bio-Rad Protein Assay Bio-Rad, Hercules, CA, USA) [86].”
MethodSelf-citationBiallelic ADPRHL2 mutations in complex neuropathy affect ADP ribosylation and DNA damage response
Beijer, D., Agnew, T., Rack, J. G. M., Prokhorova, E. A., Deconinck, T., Ceulemans, B., Perić, S., Rašić, V. M., Jonghe, P. D., Ahel, I., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202101057 · Cited by 29
“…vol 4 | no 11 | e202101057 10 of 15 Mitochondrial dysfunction is a prominent pathomechanism for neurological and in particular neurodegenerative diseases, such as Huntington’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis (Stanga et al, 2020).”
BackgroundPediatric single large-scale mtDNA deletion syndromes: The power of patient reported outcomes
Reynolds, E., Byrne, M., Ganetzky, R. D., & Parikh, S. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.11.004 · Cited by 25
Mitochondrial Protein Import Dysfunction in Pathogenesis of Neurodegenerative Diseases
Goyal, S., & Chaturvedi, R. K. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02200-0 · Cited by 26
Inequality in the Frequency of the Open States Occurrence Depends on Single 2H/1H Replacement in DNA
Басов, А. А., Drobotenko, M. I., Svidlov, A. A., Gerasimenko, E. O., Malyshko, V. V., Елкина, А. А., Baryshev, M., & Dzhimak, S. S. (2020) · Molecules · doi:10.3390/molecules25163753 · Cited by 23
“In addition, the mechanisms of DDW influence on biological systems from the point of view of the medical biochemistry are logically explained by a modification in the mitochondria energy balance [22,23].”
BackgroundMitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms
Karbowski, M., Oshima, Y., & Verhoeven, N. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04604-8 · Cited by 23
“Several recent reviews, including [39, 82, 83], discuss the role of mitochondrial dysfunction in HD development in more detail.”
BackgroundRomano, L. E. L., Aw, W. Y., Hixson, K. M., Novoselova, T. V., Havener, T. M., Howell, S., Taylor‐Blake, B., Hall, C. L., Xing, L., Beri, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111580 · Cited by 23
“For example, diverse neurodegenerative diseases exhibit altered mitochondrial dynamics and intermediate filament phenotypes (Didonna and Opal, 2019; Stanga et al., 2020), although whether these phenotypes are causal or merely components of a conserved neurodegenerative cascade is an important unanswered question (Gan…”
BackgroundSonsalla, G., Malpartida, A. B., Riedemann, T., Gušić, M., Rusha, E., Bulli, G., Najas, S., Janjic, A., Hersbach, B. A., Smialowski, P., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.12.020 · Cited by 20
“2,3 These negative ef- fectsforpre-existingneuronsalsohamperdirectneuronalconver-sionfromglialcells.”
Prasuhn, J., Göttlich, M., Ebeling, B., Kourou, S., Gerkan, F., Bodemann, C., Großer, S. S., Reuther, K., Hanßen, H., & Brüggemann, N. (2022) · Neurology · doi:10.1212/wnl.0000000000201288 · Cited by 17
Martino, R. D., Sisalli, M. J., Sirabella, R., Notte, S. D., Borzacchiello, D., Feliciello, A., Annunziato, L., & Scorziello, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158177 · Cited by 18
Dang, M., Wu, L., & Zhang, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141677 · Cited by 18
Palacios, A. G., Zhang, S. X., & Acosta, M. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70497 · Cited by 17
“139 Increased ER stress can also disrupt the calcium homeostasis in the ER, which serves as a primary reservoir of intra-cellular calcium, resulting in aberrant calcium flux to the mitochondria via the physical mitochondria-ER contact site namely mitochondria-associated ER membrane (MAM).”
Șerban, M., Toader, C., & Covache-Busuioc, R.-A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168072 · Cited by 18
Simões, R. F., Oliveira, P. J., Cunha‐Oliveira, T., & Pereira, F. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063009 · Cited by 17
“depolarization, decreased adenosine triphosphate (ATP) production, and mitochondrial DNA (mtDNA) damage with concomitant cell death [8,9].”
Backgroundvan Rensburg, D. J., Lindeque, J. Z., Harvey, B. H., & Steyn, S. F. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.03.002 · Cited by 13
Mitochondrial and Neuronal Dysfunctions in L1 Mutant Mice
Congiu, L., Granato, V., Loers, G., KLEENE, R. B., & Schachner, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084337 · Cited by 13
Banerjee, A., Pradhan, L. K., Sahoo, P. K., Jena, K. K., Chauhan, N. R., Chauhan, S., & Das, S. K. (2021) · Archives of Microbiology · doi:10.1007/s00203-021-02276-9 · Cited by 14
Menduti, G., & Boido, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914689 · Cited by 14
“diseases (such as AD), being also considered one of the triggering factors of disease onset and progression [64,84].”
BackgroundSelf-citationMitochondrial Dysfunction in Parkinson’s Disease: A Contribution to Cognitive Impairment?
Scorziello, A., Sirabella, R., Sisalli, M. J., Tufano, M., Giaccio, L., D’Apolito, E., Castellano, L., & Annunziato, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111490 · Cited by 12
“Over the last decade, alterations in mitochondrial function have been considered central to the pathogenesis of sporadic and familial forms of PD and have been included among the most common cell autonomic mechanisms leading to neuronal degeneration [138–140].”
BackgroundPresenilin-Deficient Neurons and Astrocytes Display Normal Mitochondrial Phenotypes
Contino, S., Vrancx, C., Suelves, N., Vadukul, D. M., Payen, V. L., Stanga, S., Bertrand, L., & Kienlen‐Campard, P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.586108 · Cited by 12
“Several studies have put forth a “mitochondrial cascade hypothesis” (Swerdlow and Khan, 2004; Stanga et al., 2020), according to which mitochondrial alterations are capable of initiating compensatory events that would result in the histopathological sequence of AD, including an increased production of the amyloid-β (A…”
BackgroundSelf-citationBarba‐Aliaga, M., & Alepuz, P. M. (2022) · FEBS Letters · doi:10.1002/1873-3468.14366 · Cited by 10
Baranovičová, E., Hnilicová, P., Kalenská, D., Kaplán, P., Kovalská, M., Tatarková, Z., Tomašcová, A., & Lehotský, J. (2022) · Biomolecules · doi:10.3390/biom12040554 · Cited by 11
D’Acunto, E., Gianfrancesco, L., Serangeli, I., D’Orsi, M., Sabato, V., Guadagno, N. A., Bhosale, G., Caristi, S., Failla, A., Jaco, A. D., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04463-3 · Cited by 9
“A delay in the onset of clinical manifestations is common to many neurodegenerative diseases, even in the presence of causative mutations [43].”
BackgroundLigand-free mitochondria-localized mutant AR-induced cytotoxicity in spinal bulbar muscular atrophy
Feng, X., Cheng, X., Zheng, P., Li, Y., Hakim, J. M. C., Zhang, S. Q., Anderson, S. M., Linask, K. L., Prestil, R., Zou, J., et al. (2022) · Brain · doi:10.1093/brain/awac269 · Cited by 9
Lighting Up Ca2+ Dynamics in Animal Models
Redolfi, N., García-Casas, P., Fornetto, C., Sonda, S., Pizzo, P., & Pendin, D. (2021) · Cells · doi:10.3390/cells10082133 · Cited by 11
Głuchowska, A., Kalenik, B., Kulawiak, B., Wrzosek, A., Szewczyk, A. M., Bednarczyk, P., & Mosieniak, G. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111871 · Cited by 10
“These changes indicate the deregulation of mitochondrial biogenesis during VSMC senescence, as also described for other cell types (Stanga et al., 2020).”
Neuropharmacological Study on Capsaicin in Scopolamine-injected Mice
Tyagi, S., & Thakur, A. K. (2023) · Current Alzheimer Research · doi:10.2174/0115672050286225231230130613 · Cited by 8
Secondary mitochondrial dysfunction across the spectrum of hereditary and acquired muscle disorders
Mak, G., Tarnopolsky, M. A., & Lu, J. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101945 · Cited by 9
Mahamoud, R., Bowman, D. T., Ward, W. E., & Mangal, V. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.139068 · Cited by 7
Sun, L., Liu, H., Qian, Z., Zhang, Z., Wu, H., Wu, K., Guo, N., Qu, D., Gu, X., & Zhao, C. (2025) · Science China Chemistry · doi:10.1007/s11426-024-2548-1 · Cited by 6
Zhang, L., Xie, F. X., Wang, X., Sun, Z., Wu, Y., Sun, Z., Zhang, S., Chen, X., Zhao, Y., & Qian, L. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103668 · Cited by 9
“Elevated Hcy levels have been found to be an independent risk factor in various diseases [13 – 15], with Abbreviations: Hcy, homocysteine; 6 mA, N6-methyldeoxyadenosine; mtDNA, mitochondrial DNA; MS, maternal separation; TFAM, mitochondrial transcription factor A; BDNF, brain-derived neurotrophic…”
Zhou, K., Wu, G. E., Dong, R., Kan, C., Xie, L., Gao, L., Li, H., Sun, J., & Ning, W. (2025) · Cell Regeneration · doi:10.1186/s13619-025-00242-0 · Cited by 5
“Mitochondrial DNA mutations or protein alterations are known to cause mitochondrial swelling and membrane destructions (Stanga et al. 2020).”
Zhang, L., Ge, Y., Wu, J., Wang, M., Huang, N., & Luo, Y. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01624-3 · Cited by 7
“Impaired mitochondrial energy metabolism, oxidative stress imbalance, disturbed calcium homeostasis, and disturbed mitochondrial dynamics play key roles in NDs (Stanga et al. 2020).”
da Costa, M. D. A., de Rezende, V. L., Bolan, S. J., Ebs, M. F. P., da Silva, G., Pellegrini, L. V., dos Santos, L. S., dos Santos, J. C. C., & Gonçalves, C. L. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2623966 · Cited by 5
Chaudhary, S., Rawat, S., Mathur, S., Perveen, A., Hafeez, A., Bilgrami, A. L., & Ashraf, G. M. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2520707 · Cited by 8
“These substances consist of chemically produced substances, ion-specific antioxidants, co-enzyme Q10, vitamins A, B3, D, and E, antioxidant-rich nutritional supplements, and polyphenols that work to restore mitochondrial dynamics [51–53].”
Disturbances in Muscle Energy Metabolism in Patients with Amyotrophic Lateral Sclerosis
Parvanovova, P., Hnilicová, P., Kolísek, M., Tatarková, Z., Halášová, E., Kurča, E., Holubcikova, S., Koprušáková, M. T., & Baranovičová, E. (2024) · Metabolites · doi:10.3390/metabo14070356 · Cited by 6
“Many studies confirmed mitochondrial dysfunction in ALS patients (reviewed, e.g., [12–14]), which seems to be one of the key manifestations of ALS disease.”
BackgroundNeuroenergetic Changes in Patients with X‐Linked Dystonia‐Parkinsonism and Female Carriers
Prasuhn, J., Henkel, J., Algodon, S. M., Uter, J. C., Rosales, R. L., Klein, C., Steinhardt, J., Diesta, C. C. E., & Brüggemann, N. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.14001 · Cited by 4
“10,11 Given the high energy demands of neurons and their reliance on ef fi cient mitochondrial function, even subtle disturbances in bioenergetics can profoundly affect neuronal homeostasis and predispose to or foster neurodegeneration.”
BackgroundSquillace, A., Fernando, M. G., Sullivan, K. E., Kiat, H., & Martins, R. N. (2026) · Antioxidants · doi:10.3390/antiox15010078 · Cited by 6
“This cascade leads to synaptic degeneration and neuronal loss, contributing to progressive brain atrophy due to the limited regenerative capacity of the central nervous system [5–8].”
InfluentialUy, N. P., He, M. T., Lee, C.-D., Lee, Y., Kang, K. S., & Lee, S. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119933 · Cited by 3
Hu, X., Wu, L., Wen, Y., Liu, J., Li, H., Zhang, Y., Wang, Z., Ding, J., Zeng, Z., & Xia, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9253916 · Cited by 4
“Interestingly, mitochondrial dysfunction is one of the initiating events in many pathologies [44].”
BackgroundDeng, L., Gòdia, M., Derks, M. F. L., Harlizius, B., Farhangi, S., Tang, Z., Groenen, M. A. M., & Madsen, O. (2025) · Genomics · doi:10.1016/j.ygeno.2025.111026 · Cited by 2
НЕЙРОПРОТЕКТОРНІ ВЛАСТИВОСТІ α-ЛІПОЄВОЇ КИСЛОТИ У ХВОРИХ НА ДІАБЕТ
SOKOLOVA, L. K., Vm, P., & Tronko, M. D. (2021) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2021.4.19 · Cited by 2
Iseppon, F., Malacrida, A., Chiorazzi, A., Canta, A., Alberti, P., Carozzi, V., Pozzi, E., Rodriguez‐Menendez, V., Cherchi, L., Fabbro, V., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70501 · Cited by 2
“Mitochondria are organized in a continuously remodelling network, regulated by a constant cycle of fusion and fission events, which influences cell functionality beyond energy production (Stanga et al., 2020; Tábara et al., 2025).”
Self-citationLai, C., Xia, H., ZHANG, Y., He, Y., Wu, X., Ye, B., Yang, H. Y., & Zhang, B. (2026) · Life · doi:10.3390/life16071206 · Cited by 1
“PCA also functions as an efficient peroxyl radical scavenger in polar aqueous environments and retains free radical-scavenging activity in nonpolar lipid environments, indicating adaptive antioxidant potential across physiological microenvironments [28].”
Okoh, M. P., & Alli, L. A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102571 · Cited by 1
Bata-García, J. L., Solís-Uicab, G. C., Alcocer-Sosa, J. J., Hernández-Monsrreal, K. C., & Perez-Osorio, C. E. (2024) · International Journal of Health Science · doi:10.22533/at.ed.1594242423024 · Cited by 1
Coenzyme Q10: Does it benefit neurological diseases?
Chen, T. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3012862
Zhao, Y. F., Zhang, L., Xie, F. X., Wang, X., Sun, Z., Wu, Y., Sun, Z., Zhang, S., Chen, X., & Qian, L. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5202031
Progress in stem cells mitochondrial proteomics research: A review
Yao, W., Yu, X., Wang, Y., & xia, L. (2025) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/203862
Mitochondrial dysfunction in cellular senescence
Solomko, L., Kussainova, A., & Bulgakova, O. (2025) · Fundamental and Experimental Biology · doi:10.31489/2025feb3/5-17
Li, W., Yang, D., Zhang, Z., Wang, M., Xu, S.-L., Jiang, R., Chen, J., Wu, C., & Qian, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1667421 · Cited by 2
Belforte, N., Agostinone, J., Alarcón-Martínez, L., Villafranca‐Baughman, D., Dotigny, F., Vargas, J. C., & Polo, A. D. (2021) · Figshare · doi:10.6084/m9.figshare.14880590
Belforte, N., Agostinone, J., Alarcón-Martínez, L., Villafranca‐Baughman, D., Dotigny, F., Vargas, J. C., & Polo, A. D. (2021) · Figshare · doi:10.6084/m9.figshare.14880593
Dallere, S., Mattioni, A., Turégano-López, M., Blázquez‐Llorca, L., Merchán-Pérez, Á., Schellino, R., Vercelli, A., DeFelipe, J., & Boido, M. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01814-7
Self-citationZhang, J., Ma, Y., Feng, L., Xie, M., Wang, Y., Yang, L., Cai, Y., Yu, X., & Xu, L. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.172529
Zhao, Z., Yang, L., Zhang, Z., Song, J., Zhang, C., & Duan, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031599
“Additionally, it restores Akt pathway activity suppressed by oxidative stress and inhibits H 2 O 2 -induced overoxidation of DJ-1 in SH-SY5Y cells [15].”
Développement de peptides ciblant VDAC pour l’étude et le traitement de maladies démyélinisantes
Jacquard, M. F. (2023) · theses.fr (ABES) · doi:10.70675/33c8bd67z22cfz47b0zb14bz58b975b2f7d4
Saleki, S., Wabant, C., Loriot, A. E., Stanga, S., Masquelier, J., Muccioli, G. G., Suelves, N., & Kienlen‐Campard, P. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116045 · Cited by 1
Self-citationCaretto, A., Cunto, F. D., Abonce, S. E. V., Hassan, A., di Vito, R., Menduti, G., Usiello, A., Boido, M., & Vercelli, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-74597-y
Self-citation
Metadata
- Authors
- Stanga, S., Caretto, A., Boido, M., & Vercelli, A.
- Affiliations
- Neuroscience Institute Cavalieri Ottolenghi (IT)
- Corresponding author
- Stanga, Serena
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-05-25
- Volume
- 21
- Issue
- 10
- Pages
- 3719
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7279270
- OpenAlex
- W3026090014
- Cited by
- 90
- References
- 244
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 10 · 2023: 8 · 2022: 18 · 2021: 23 · 2020: 10
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca (“Dipartimenti di Eccellenza 2018–2022” to Department of Neuroscience “Rita Levi Montalcini)
- Fondazione CRT (RF 2017.2052)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- mitochondrial dysfunction, neurodegenerative diseases, neurodegeneration, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, mitochondrial morphology, mitochondrial-targeted drugs, cellular senescence, DNA damage
- MeSH terms
- Alzheimer Disease, Amyotrophic Lateral Sclerosis, Animals, Antioxidants, Organelle Biogenesis, Humans, Mitochondria, Muscular Atrophy, Spinal, Parkinson Disease, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.